Rockwell iron deficiency drug meets trial goal, shares soar
Feb 4 (Reuters) - Rockwell Medical said a clinical study showed that regular administration of its experimental treatment for iron deficiency reduced the need for additional agents to boost red blood cell production by 37 percent.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here